Cargando…
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a range of biological processes implicated in the response to growth factors like latelet-derived growth factor (PDGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and stress, such as...
Autores principales: | Cicenas, Jonas, Zalyte, Egle, Rimkus, Arnas, Dapkus, Dalius, Noreika, Remigijus, Urbonavicius, Sigitas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789351/ https://www.ncbi.nlm.nih.gov/pubmed/29267206 http://dx.doi.org/10.3390/cancers10010001 |
Ejemplares similares
-
Starvation mediates pancreatic cancer cell sensitivity to ferroptosis via ERK1/2, JNK and changes in the cell mesenchymal state
por: Zalyte, Egle, et al.
Publicado: (2022) -
SGK1 in Cancer: Biomarker and Drug Target
por: Cicenas, Jonas, et al.
Publicado: (2022) -
Kinases and Cancer
por: Cicenas, Jonas, et al.
Publicado: (2018) -
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
por: Wang, Xiaojie, et al.
Publicado: (2012) -
p38MAPK/SGK1 signaling regulates macrophage polarization in experimental autoimmune encephalomyelitis
por: Li, Bo, et al.
Publicado: (2019)